Business Club News, January 21
Last year, 84% of 537 Chinese herbal medicines on the national market experienced price increases, which ranged from 5% to 180%. In January 2011, industry analysts said that Chinese herbal medicines prices will no longer skyrocket like bullets. In addition to the prices of valuable herbal medicines, which are still a few tonics, prices of Chinese herbal medicines have declined.
In early January, half of the prices of common herbs were stable
In the winter season, due to the season of topping-up, there is usually no obvious drop in prices. However, from the market point of view, this year is another scene. According to the trend of real estate medicinal herbs provided by the Chinese Traditional Medicine Association in early January of this year, more than half of the 75 common medicinal materials such as soups, rhizomes, and mosaics are stable.
The latest quotation from the Chinese herbal medicine company Tiandi.com showed that on January 5th, wholesale prices of Chinese herbal medicines such as Panax notoginseng, Banlangen, Sterculia lychnophora and Astragalus membranaceus had begun to decline. The market price of Hawthorn maintains a correction trend, and the current market price is 50-55 yuan/kg, which has been adjusted back from a high of 65 yuan. The price of Sanchi was about 365 yuan/kg in December last year, and this month was 355 to 359 yuan/kg. Guo Fanli, a researcher in the pharmaceutical industry of China Investment Advisors, told the writer that some medicine prices have gradually dropped after the start of the year. "This is undoubtedly a signal." .
This year's price changes have become increasingly stable
Zhang Yuan analysis of the Chinese herbal medicine market said that the new price law regulations at the end of last year will increase the attack on malicious hoarding. Therefore, this year's market will no longer see the rise of large quantities of Chinese herbal medicines as in the first half of last year. The price of medicinal herbs will rise rapidly and prices of medicinal herbs will gradually increase. It tends to be reasonable, and there may be hot scenes in the Chinese herbal medicine market. For example, varieties with lower price and contradictions between supply and demand will rise to a higher level next year, such as: Baiji, Danpi, Huanglian, Xiaoliangjiang, raw land, and cattle. Knees, Shichangpu and other species may develop into hot spots for businesses next year. However, there will be no overheating, and then the Chinese herbal medicine market will enter the actual digestion period, and the market will run smoothly. Guo Fanli also stated that if the control of the hot money is good, the major natural disasters will appear less frequently, and the overall price of Chinese herbal medicines will gradually fall back this year. Some Chinese herbal medicines, such as Taizi Shenshen, are expected to be returned to their original shape.
Establishing a medicinal base is a king
Chinese medicine companies subject to the price of Chinese herbal medicines are skyrocketing. They are actively seeking changes. Starting last year, many companies have turned their attention to the construction of herbal medicine bases. Guizhou Braun recently issued an announcement saying that on January 11 this year, its wholly-owned subsidiary, Guizhou Braun Group Pharmaceutical Sales Co., Ltd. (abbreviated as Pharmaceutical Sales Company) and the Liuzhi Special Zone Farming and Breeding Farmers' Professional Cooperative signed the "medicinal plant commission contract 》
The competition for resources such as the cultivation base of Chinese medicine will also become increasingly heated. Whoever has the ability to seize resources in the future will also indicate who will have a higher market share. Shenwei Pharmaceutical official said that the rising raw material prices in 2010 will exert some pressure on the company's costs. To this end, the pharmaceutical industry has begun to adopt a series of measures to change the predicament and will build its own planting base in 2011 so that it can control prices, ensure stable supply, and solve the sustainable development of enterprises. Previously, Li Chuyuan, chairman of Guangyao Pharmaceutical Group, told the author that Guangyao Pharmaceutical Group has reached 20 medicine bases both at home and abroad, and has become the country's largest medical group with a base of Chinese herbal medicines. At the end of the “Twelfth Five-Year Planâ€, Guangpharm Group will build 30 new GAP bases for the cultivation of Chinese herbal medicines, eventually forming a base for 50 herbal medicine bases.
Last year, 84% of 537 Chinese herbal medicines on the national market experienced price increases, which ranged from 5% to 180%. In January 2011, industry analysts said that Chinese herbal medicines prices will no longer skyrocket like bullets. In addition to the prices of valuable herbal medicines, which are still a few tonics, prices of Chinese herbal medicines have declined.
In early January, half of the prices of common herbs were stable
In the winter season, due to the season of topping-up, there is usually no obvious drop in prices. However, from the market point of view, this year is another scene. According to the trend of real estate medicinal herbs provided by the Chinese Traditional Medicine Association in early January of this year, more than half of the 75 common medicinal materials such as soups, rhizomes, and mosaics are stable.
The latest quotation from the Chinese herbal medicine company Tiandi.com showed that on January 5th, wholesale prices of Chinese herbal medicines such as Panax notoginseng, Banlangen, Sterculia lychnophora and Astragalus membranaceus had begun to decline. The market price of Hawthorn maintains a correction trend, and the current market price is 50-55 yuan/kg, which has been adjusted back from a high of 65 yuan. The price of Sanchi was about 365 yuan/kg in December last year, and this month was 355 to 359 yuan/kg. Guo Fanli, a researcher in the pharmaceutical industry of China Investment Advisors, told the writer that some medicine prices have gradually dropped after the start of the year. "This is undoubtedly a signal." .
This year's price changes have become increasingly stable
Zhang Yuan analysis of the Chinese herbal medicine market said that the new price law regulations at the end of last year will increase the attack on malicious hoarding. Therefore, this year's market will no longer see the rise of large quantities of Chinese herbal medicines as in the first half of last year. The price of medicinal herbs will rise rapidly and prices of medicinal herbs will gradually increase. It tends to be reasonable, and there may be hot scenes in the Chinese herbal medicine market. For example, varieties with lower price and contradictions between supply and demand will rise to a higher level next year, such as: Baiji, Danpi, Huanglian, Xiaoliangjiang, raw land, and cattle. Knees, Shichangpu and other species may develop into hot spots for businesses next year. However, there will be no overheating, and then the Chinese herbal medicine market will enter the actual digestion period, and the market will run smoothly. Guo Fanli also stated that if the control of the hot money is good, the major natural disasters will appear less frequently, and the overall price of Chinese herbal medicines will gradually fall back this year. Some Chinese herbal medicines, such as Taizi Shenshen, are expected to be returned to their original shape.
Establishing a medicinal base is a king
Chinese medicine companies subject to the price of Chinese herbal medicines are skyrocketing. They are actively seeking changes. Starting last year, many companies have turned their attention to the construction of herbal medicine bases. Guizhou Braun recently issued an announcement saying that on January 11 this year, its wholly-owned subsidiary, Guizhou Braun Group Pharmaceutical Sales Co., Ltd. (abbreviated as Pharmaceutical Sales Company) and the Liuzhi Special Zone Farming and Breeding Farmers' Professional Cooperative signed the "medicinal plant commission contract 》
The competition for resources such as the cultivation base of Chinese medicine will also become increasingly heated. Whoever has the ability to seize resources in the future will also indicate who will have a higher market share. Shenwei Pharmaceutical official said that the rising raw material prices in 2010 will exert some pressure on the company's costs. To this end, the pharmaceutical industry has begun to adopt a series of measures to change the predicament and will build its own planting base in 2011 so that it can control prices, ensure stable supply, and solve the sustainable development of enterprises. Previously, Li Chuyuan, chairman of Guangyao Pharmaceutical Group, told the author that Guangyao Pharmaceutical Group has reached 20 medicine bases both at home and abroad, and has become the country's largest medical group with a base of Chinese herbal medicines. At the end of the “Twelfth Five-Year Planâ€, Guangpharm Group will build 30 new GAP bases for the cultivation of Chinese herbal medicines, eventually forming a base for 50 herbal medicine bases.
Stubble Rotary Crusher,50HP Stubble Rotary Crusher,Dual Shaft Crusher,Tractor Drived Stubble Rotary Crusher
Shandong Dahua Machinery Co.,Ltd , https://www.agrodahua.com